RAZADYNE ER |
021615 |
001 |
NDA |
GALANTAMINE HYDROBROMIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2005/04/01
|
2005/04/01
|
JANSSEN PHARMS |
Discontinued |
RAZADYNE ER |
021615 |
002 |
NDA |
GALANTAMINE HYDROBROMIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 16MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2005/04/01
|
2005/04/01
|
JANSSEN PHARMS |
Discontinued |
RAZADYNE ER |
021615 |
003 |
NDA |
GALANTAMINE HYDROBROMIDE |
CAPSULE, EXTENDED RELEASE;ORAL |
EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2005/04/01
|
2005/04/01
|
JANSSEN PHARMS |
Discontinued |